Cardinal Health, Inc. (CAH)

Market Cap	37.22B
Revenue (ttm)	222.58B
Net Income (ttm)	1.56B
Shares Out	237.58M
EPS (ttm)	6.45
PE Ratio	24.29
Forward PE	16.60
Dividend	$2.04 (1.30%)
Ex-Dividend Date	Oct 1, 2025

Volume	1,316,192
Open	155.19
Previous Close	155.19
Day's Range	153.31 - 156.68
52-Week Range	106.98 - 168.44
Beta	0.72
Analysts	Buy
Price Target	161.43 (+3.05%)
Earnings Date	Oct 30, 2025

About CAH

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products....

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1979
• Employees: 57,700
• Stock Exchange: NYSE
• Ticker Symbol: CAH
• Website: https://www.cardinalhealth.com

Financial Performance

In 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.

Analyst Summary

According to 14 analysts, the average rating for CAH stock is "Buy." The 12-month stock price target is $161.43, which is an increase of 3.05% from the latest price.

Price Target

$161.43

(3.05% upside)

Analyst Consensus: Buy